enfr

Publications

1- DUBUISSEZ, M, P. FAIDERBE, S. PINTE, V. DEHENNAUT and D.LEPRINCE
The reelin receptors ApoER2 and VLDLR are direct target genes of HIC1
Bioch. Biophys. Res. Comm., (2013) 440 : 424-430

2- LIN, Y-M., J-C. JENG, C-M. WANG, D.LEPRINCE and H-M. SHIH-
HIC1 interacts with and modulates the activity of STAT3
Cell Cycle, (2013), 12 : 2266-2276

3- SUN, L., J. CHEN, H. LI, V. DEHENNAUT, Y. ZHAO, Y. YANG, Y. IWASAKI, B. KAHN-PERLES, D. LEPRINCE, Q. CHEN, Y. XU and A. SHEN
SUMOylation dependent pathway regulates SIRT1 transcription and lung cancer metastasis.
J. Natl. Cancer Inst., (2013) 105 : 887-898
4- DEHENNAUT, V., I. LOISON, G. BOULAY, S. PINTE, C. Van RECHEM and D.LEPRINCE
Identification of P21 (CIP/WAF1) as a direct target gene of HIC1 (Hypermethylated in Cancer 1).
Bioch. Biophys. Res. Comm., (2013), 430: 49-53

5- DEHENNAUT, V., I. LOISON, M. DUBUISSEZ, J. NASSOUR, C. ABBADIE and D.LEPRINCE
DNA double strand breaks lead to activation of Hypermethylated in Cancer 1 (HIC1) by SUMOylation to regulate DNA repair.
J Biol. Chem., (2013), 288 : 10254-10264

2012

1-    DEHENNAUT, V., I. LOISON, S. PINTE and D.LEPRINCE
Molecular dissection of the interaction between HIC1 and SIRT1
Bioch. Biophys. Res. Comm., (2012), 421 : 384-388

2- BOULAY, G., M. DUBUISSEZ, C. Van RECHEM, A. FORGET, K. HELIN, O. AYRAULT and D. LEPRINCE
HIC1 recruits PRC2 to its target genes through interaction with hPCL (human Polycomb-like) proteins.
J. Biol. Chem., (2012) 287 : 10509-10524

3- FOVEAU, B., G. BOULAY, S. PINTE, C. Van RECHEM, B.R. ROOD and D. LEPRINCE
Receptor tyrosine Kinase EphA2 is a direct target gene of HIC1 (Hypermethylated in Cancer 1)
J. Biol. Chem., (2012), 287 : 5366-5378

4- BOULAY, G., N. MALAQUIN, I. LOISON, B. FOVEAU, C. Van RECHEM, B.R. ROOD, A. POURTIER and D. LEPRINCE
Loss of HIC1 (Hypermethylated in Cancer 1) in breast cancer cells predisposes to stress induced migration and invasion through -2 Adrenergic receptor misregulation.
    J. Biol. Chem., (2012) 287 : 5379-5389

2011

1- BOULAY, G., C.ROSNOBLET, C.GUERARDEL, P.-O.ANGRAND and D.LEPRINCE
Functional characterization of hPCL3 (human Polycomb-like 3) isoforms identifies distinct EZH2 protein complexes.
Biochemical Journal, (2011), 434 : 333-342
2- POSPICHALOVA, V., J.TURECKOVA, B.FAFILEK, M.VOJTECHOVA, M.KRAUSOVA, J.LUCAS, E.SLONCOVA, S.TAKACOVA, V.DIVOKY, D.LEPRINCE, J.PLACHY and V.KORINEC
Generation of two modified mouse allele of the Hic1 tumor suppressor gene
Genesis, (2011), 49 : 142-151

2010

1- Van RECHEM, C., G.BOULAY, S.PINTE, N.STANKOVIC-VALENTIN, C.GUERARDEL, and D.LEPRINCE
Differential regulation of HIC1 target genes by CtBP and NuRD via an acetylation/SUMOylation switch, in quiescent versus proliferating cells
Molecular and Cellular Biology, (2010), 30 : 4045-4059

2- GUINEZ, C., AM. MIR, N.MARTIN, D.LEPRINCE, JC.MICHALSKI, G.VERGOTEN and T.LEFEBVRE
Arginine 469 is pivotal residue for the Hsc70-GlcNAc binding property.
Bioch. Biophys. Res. Comm., (2010), 400 : 537-42.

2009

1- Van RECHEM, C., G. BOULAY, and D.LEPRINCE
HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A
Bioch. Biophys. Res. Comm., (2009), 385 : 586-590

2- DEHENNAUT, V. et D.LEPRINCE
Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response.
Electronic J of Oncology/Bulletin du Cancer (2009), 96, 66-72.

3- Van RECHEM, C., B.R. ROOD, S. PINTE, M. TOUKA, M. JENAL, C.GUERARDEL, K. RAMSEY, D. MONTE, A. BEGUE, M.P. TSCHAN, D.A. STEPHAN and D.LEPRINCE
The scavenger chemokine (C-X-C motif) receptor 7 is a direct target gene of Hypermethylated in Cancer 1 (HIC1)
J Biol. Chem., (2009), 284 : 20927-20935

4- FLEURIEL, C., M. TOUKA, G. BOULAY, C. GUERARDEL, ROOD, B.R. and D.LEPRINCE
HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.
Int. J. of Biochemistry and Cell Biology (2009), 41: 26-33

5- JENAL, M., E.TRINH, C. BRITSCHGI, A. BRITSCHGI, V. ROH, S.A. VORBURGER, A. TOBLER, D. LEPRINCE, M.F. FEY, K. HELIN and M.P. TSCHAN
The tumor suppressor gene Hypermethylated in Cancer 1 is transcriptionally regulated by E2F1
Mol. Cancer Res., (2009) 7 : 916-22